Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Latest Media
Fermentation technology: cooking up new therapeutics
With a new state-of-the-art, cGMP fermentation facility in Jerusalem, SAFC is looking at new applications for what is viewed by many as a traditional technology. These applications include the synthesis of High Potency Active Pharmaceutical Ingredients (HPAPIs) and therapeutic drugs
Trends in the manufacturing of viral gene therapeutics and next generation vaccines
Gene therapy is still an experimental technology, but the dangers are now much better understood, according to Jeff Strobel, site director, SAFC Carlsbad, CA
Handling protocols: key consideration in HPAPI market
Over the past 10 years, the manufacture of highly potent APIs has become increasingly attractive to contract manufacturers, says Trevor Calkins, director of process development, SAFC
Linking biological molecules to highly potent APIs
Antibody-drug conjugate technology is the ‘smart bomb’ in the arsenal of weapons used to target cancer cells, says Cynthia Wooge, SAFC process development manager
IR spectroscopy on the move
Perkin Elmer\'s latest spectrometer, Spectrum Two, brings spectroscopy to the non-specialist
Temperature tracking
As clinical trial sites move to distant geographic areas and more biologics are involved, temperature monitoring of drug shipments becomes a growing need. Almac has responded with a system it believes will transform temperature monitoring for clinical trials
Case study: Five years of trouble-free manufacturing for large pharma company
Alkermes, through the merger with Elan Drug Technologies, to become Alkermes plc, has been developing and manufacturing commercial scale solid oral dosage products for more than 40 years. This case study demonstrates a large pharmaceutical contract manufacturing engagement in which there has been five years trouble-free supply with OTIF (On-Time-In-Full) consistently >95%.<br> Process and product improvement initiatives were also delivered, which enabled significant capacity and yield improvements. These improvements resulted in significant cost savings for our partner.
Previous
1
2
3
4
(current)
Next
Trending Articles
From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND
Join ACG in partnership with Manufacturing Chemist for an expert-led session to explore how different wet granulation methods impact consistency, yield, and quality — and what really matters when it comes to selecting and optimising your process
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles
Manufacturing Chemist Stand Side with IMA S.p.A
Guia Bertuzzi, Product Manager at IMA Active division talks to Manufacturing Chemist about its flagship product CROMA, finalist at this years' CPHI Awards
Case study: Five years of trouble-free manufacturing for large pharma company
Alkermes, through the merger with Elan Drug Technologies, to become Alkermes plc, has been developing and manufacturing commercial scale solid oral dosage products for more than 40 years. This case study demonstrates a large pharmaceutical contract manufacturing engagement in which there has been five years trouble-free supply with OTIF (On-Time-In-Full) consistently >95%.<br> Process and product improvement initiatives were also delivered, which enabled significant capacity and yield improvements. These improvements resulted in significant cost savings for our partner.
On-line TOC and ozone measurement for pharmaceutical waters
The quality of pharmaceutical waters used in product manufacturing must meet all International Pharmacopeia regulations. Any out-of-specified conditions must be identified and corrected immediately
Upcoming event
Making Pharmaceuticals
21–22 April 2026 | Exhibition | Coventry, UK
See all